Monte Rosa Therapeutics Inc (GLUE) earnings · rev $123.7M
These earnings events as JSON? API free 100/dayMonte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
This GLUE earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported GLUE revenue for 2025-12-31 was $123.7M. Net income was -$38.6M. Revenue was up 63.5% from 2024-12-31 to 2025-12-31. GLUE currently screens at market cap $1.56B.
When the next GLUE 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 63.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full GLUE research stays on the stock page; the tape stays on the quote page.
GLUE earnings FAQ
What are GLUE's latest revenue and net income?
Latest cached Monte Rosa Therapeutics Inc (GLUE) revenue for Dec 31, 2025 was $123.7M. Net income was -$38.6M. Statements: https://lician.com/financials/glue
What period does the latest GLUE earnings print cover?
The latest cached Monte Rosa Therapeutics Inc (GLUE) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did GLUE revenue change from the prior cached period?
Cached Monte Rosa Therapeutics Inc (GLUE) revenue was up 63.5% from $75.6M (Dec 31, 2024) to $123.7M (Dec 31, 2025). Statements: https://lician.com/financials/glue
Where are GLUE earnings listed?
Cached earnings facts for Monte Rosa Therapeutics Inc (GLUE) are listed at https://lician.com/earnings/glue. Statements: https://lician.com/financials/glue
Not investment advice.